NasdaqGM - Nasdaq Real Time Price USD

Evolus, Inc. (EOLS)

11.49 -0.07 (-0.61%)
As of 3:36 PM EDT. Market Open.
Loading Chart for EOLS
DELL
  • Previous Close 11.56
  • Open 11.47
  • Bid 11.48 x 100
  • Ask 11.54 x 100
  • Day's Range 11.36 - 11.54
  • 52 Week Range 7.07 - 15.43
  • Volume 172,815
  • Avg. Volume 590,603
  • Market Cap (intraday) 706.607M
  • Beta (5Y Monthly) 1.45
  • PE Ratio (TTM) --
  • EPS (TTM) -1.08
  • Earnings Date May 7, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 22.29

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

www.evolus.com

273

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EOLS

Performance Overview: EOLS

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EOLS
9.12%
S&P 500
3.97%

1-Year Return

EOLS
40.81%
S&P 500
19.36%

3-Year Return

EOLS
4.74%
S&P 500
18.49%

5-Year Return

EOLS
54.00%
S&P 500
70.72%

Compare To: EOLS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EOLS

Valuation Measures

As of 4/18/2024
  • Market Cap

    711.53M

  • Enterprise Value

    775.24M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.26

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    3.84

  • Enterprise Value/EBITDA

    -18.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -30.52%

  • Return on Assets (ttm)

    -12.30%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    202.08M

  • Net Income Avi to Common (ttm)

    -61.69M

  • Diluted EPS (ttm)

    -1.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    62.84M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -10.38M

Research Analysis: EOLS

Analyst Price Targets

16.00
22.29 Average
11.49 Current
27.00 High
 

Fair Value

Overvalued
% Return
11.49 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Research Reports: EOLS

  • Daily – Vickers Top Buyers & Sellers for 08/16/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 10/10/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 09/01/2021

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 08/30/2021

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     

People Also Watch